UCB Biopharma SRL

128 clinical trials · Sponsor

Record	Firm	Date
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03598790)	UCB Biopharma SRL	2018-09-05
Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy (NCT03370120)	UCB Biopharma SRL	2018-08-27
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03536884)	UCB Biopharma SRL	2018-06-13
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03410992)	UCB Biopharma SRL	2018-02-05
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03412747)	UCB Biopharma SRL	2018-01-26
A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis (NCT03355573)	UCB Biopharma SRL	2017-11-28
A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis (NCT03347110)	UCB Biopharma SRL	2017-11-22
A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis (NCT03215277)	UCB Biopharma SRL	2017-10-04
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. (NCT03248531)	UCB Biopharma SRL	2017-09-22

Track UCB Biopharma SRL automatically

Every clearance here is in the API, with alerts when new ones post.